Proteus Motion

3D resistance-training and strength-measurement system for elite athletes, physical therapy, and wellness.

Website: https://proteusmotion.com/

Cover Block

Public sources

Field Value
Name Proteus Motion
Tagline 3D resistance-training and strength-measurement system for elite athletes, physical therapy, and wellness [Proteus Motion, retrieved 2024]
Headquarters New York, United States [LinkedIn, retrieved 2024]
Founded 2016 [LinkedIn, retrieved 2024]
Stage Series A [Crunchbase, retrieved 2024]
Business model Hardware + Software
Industry Healthtech
Technology type Hardware
Geography North America
Growth profile Venture Scale
Founding team Solo Founder, Sam Miller [Fitt Insider, December 2021]
Funding label $10M+
Total disclosed funding Approximately $19,750,000, based on disclosed rounds of $3,000,000 in October 2021, $8,500,000 in July 2022, $7,730,000 in September 2025, and $2,750,000 in October 2025 [Sportico, October 2021] [Sports Business Journal, July 2022] [Tracxn] [Sports Business Journal, October 2025]

Links

Public sources

Executive Summary

PUBLIC Proteus Motion builds a 3D resistance-training and strength-measurement system, and it merits investor attention because the company sits at the intersection of sports performance, rehabilitation, and wellness with a product that appears differentiated on measurement rather than content or coaching alone [Forbes, March 2022] [Sports Business Journal, July 2022]. Founded in 2016 by Sam Miller, the company traces its origin to biomechanics work that Miller has said was inspired by a prototype developed by his father, Larry Miller, while the business itself was reportedly bootstrapped in its early period before raising outside capital [Fitt Insider, December 2021]. The core product combines hardware with software to measure and train force in three dimensions, a pitch that has resonated with elite-sports and therapy buyers because it aims to quantify strength and power across multiple planes rather than simply track weight moved or repetitions completed [Forbes, March 2022] [TechFundingNews, July 2022].

The team story is still founder-led in the product sense, but it has started to professionalize at the operating layer: Sports Business Journal reported that Lisa Frankovitch became CEO in October 2025, with Miller moving to Chief Product and Technology Officer [Sports Business Journal, October 2025]. That shift matters because the next phase looks less like invention and more like repeatable commercialization, especially if the company wants to extend beyond elite performance into physical therapy, gyms, wellness, and longevity use cases described in public coverage [TechFundingNews, July 2022]. On funding, the public record supports roughly $19.75 million in disclosed financing across seed, Series A, and later investment rounds, with Acies Investment, HBSE Ventures, Hospital for Special Surgery, and several athlete or sports-adjacent backers among the named investors [Sportico, 2022] [Sports Business Journal, July 2022] [Sports Business Journal, October 2025] [Tracxn].

The business model is best understood as hardware plus software, which can support deeper customer integration but also raises the usual questions around installation pace, utilization, and margin structure that public reporting does not yet answer directly [Crunchbase, retrieved 2024] [Proteus Motion, retrieved 2024]. For the next 12 to 18 months, the key public watchpoints are whether Proteus can translate early traction, including more than 100 units in use and reported usage across 41 states and parts of Canada by mid-2022, into broader institutional adoption and a clearer operating profile [Sportico, 2022] [Sports Business Journal, July 2022]. The company has enough product distinctiveness and investor support to stay on the radar, but the evidence available publicly still leaves open basic diligence questions around revenue quality, customer concentration, and the repeatability of demand outside high-performance settings.

Lightly corroborated -- Uses multiple named public sources for company history, product positioning, and financing, but several material operating claims remain company-reported or only partially corroborated.

Taxonomy Snapshot

Axis Value
Stage Series A
Business Model Hardware + Software
Industry / Vertical Healthtech
Technology Type Hardware
Geography North America
Growth Profile Venture Scale
Founding Team Solo Founder
Funding $10M+ (total disclosed ~$19,750,000)

How the Company Got Here

PUBLIC Proteus Motion presents as a New York based company built around a fairly specific claim: strength and power can be measured more usefully in three dimensions than through conventional weight-room proxies alone [Proteus Motion, retrieved 2024]. Public company materials and startup databases align on the basics that matter here. The company says it is headquartered in New York, and Crunchbase lists the business as Proteus Motion, founded in 2016 by Sam Miller [Proteus Motion, retrieved 2024] [Crunchbase, retrieved 2024].

The chronology is thin but directionally coherent. Crunchbase places the founding in 2016, while the company website frames the business around a 3D resistance-training and strength-measurement system that serves performance, rehabilitation, and related health use cases [Crunchbase, retrieved 2024] [Proteus Motion, retrieved 2024]. That does not establish every step of product development, but it does establish the company as a hardware-plus-software effort that has been in market-building mode for several years rather than a newly formed venture [Crunchbase, retrieved 2024] [Proteus Motion, retrieved 2024].

A few later milestones are visible from the same public record. Crunchbase records fundraising activity under the Proteus Motion profile, and the company website now presents add-on product surfaces such as a bat attachment alongside its core system, which suggests an expansion from a single flagship machine toward sport-specific applications [Crunchbase, retrieved 2024] [Proteus Motion, retrieved 2024]. Public sources used for this section do not clearly establish a legal entity name beyond the operating brand.

Lightly corroborated -- Core facts are supported by Crunchbase and the company website, but the legal entity detail and full milestone sequence are only partially established in those sources.

Product and Technology

Sources and analysis

Proteus Motion is selling a specific piece of training equipment, not a general fitness app. Public descriptions consistently frame the product as a 3D resistance-training and strength-measurement system that combines hardware and software to assess how users generate force across multiple planes of movement, which is the clearest through-line in the available reporting [Forbes, March 2022] [TechFundingNews, July 2022] [Proteus Motion, retrieved 2024]. Forbes reported that the product’s core differentiation is its attempt to quantify strength and power beyond conventional gym metrics such as weight lifted or repetitions completed, a framing that fits the company’s positioning with elite performance and rehabilitation buyers [Forbes, March 2022].

The public feature set is described in relatively concrete terms, even if some of the language comes from the company itself. Proteus says the system measures strength and power across human movement patterns and offers a resistance-training mode branded 3D Resistance™, while third-party descriptions say that resistance remains constant regardless of movement direction or speed [Proteus Motion, retrieved 2024] [TechFundingNews, July 2022] [Planet Fastpitch, retrieved 2026]. The company website also states that, with user consent, the device can collect health-related and session data including heart rate, heart rate variability, ambient air temperature, activity type, and exercise duration; the same site references a bat attachment being rolled out to customers, which suggests sport-specific accessories are already part of the commercial product rather than an unannounced roadmap item [Proteus Motion, retrieved 2024].

The evidence on adoption is better than the evidence on technical depth. Sports Business Journal reported in July 2022 that version 2.0 was being used by tens of thousands of users across 41 states and parts of Canada, and Sportico separately reported that more than 100 units were in use around the same period [Sports Business Journal, July 2022] [Sportico, 2022]. Those figures point to real field deployment, but the underlying software architecture, sensor stack, model layer, and data interoperability are not described in enough detail in the sourced material to support deeper technical conclusions.

Lightly corroborated -- Product category and deployment claims are corroborated by multiple public sources, but several feature-level details rely on company materials or single-source trade coverage.

Where the Demand Sits

PUBLIC The market matters because Proteus Motion sits at the intersection of performance analytics, rehabilitation, and wellness equipment, three budgets that have remained active even as buyers have become more selective about new hardware purchases [Forbes, March 2022] [Fitt Insider, December 2021].

Public evidence is thinner on formal market sizing than on product positioning, so the market case has to be built from adjacent demand signals rather than a clean third-party TAM model. The available reporting places Proteus first with elite sports organizations, professional athletes, sports-performance trainers, and physical-therapy providers, before expanding toward gyms, wellness, and longevity use cases [Forbes, March 2022] [TechFundingNews, July 2022]. That matters because each segment buys for a slightly different reason: teams and athletes pay for marginal performance gains, clinics pay for measurable assessment and rehab workflows, and commercial fitness buyers tend to pay for member differentiation and programming.

The nearest public framing of demand comes from the way reporters and the company describe the product rather than from syndicated industry data. Forbes reported that Proteus is trying to quantify strength and power across multiple planes instead of relying on one-dimensional measures such as weight lifted or repetitions, and compared the ambition to becoming the "TrackMan of power testing" [Forbes, March 2022]. If that framing holds in practice, the addressable spend is broader than a single equipment category, because the product can be sold as both a training device and a measurement system.

A direct TAM table is not supportable from the gathered sources, but the adjacent markets implied by the reporting are clear enough to map.

Adjacent market Why it is relevant to Proteus Public evidence
Elite sports performance Early wedge with pro athletes, trainers, and sports organizations that value measurable gains Forbes described elite-athlete performance training as the initial buyer wedge [Forbes, March 2022]
Physical therapy and rehabilitation Measurement-led rehab and recovery use cases widen the buyer set beyond sports teams Fitt Insider reported an early collaboration with Hospital for Special Surgery, later a customer and investor [Fitt Insider, December 2021]
Commercial fitness and wellness Expansion path into gyms, wellness, and longevity creates a larger but likely more price-sensitive channel TechFundingNews said the company has targeted gyms, wellness, and longevity markets beyond elite sports [TechFundingNews, July 2022]

The adjacent-market map suggests Proteus is pursuing a category expansion strategy rather than a narrow sports-tech niche. That broadens potential demand, but it also means the company must prove distinct ROI separately to trainers, clinicians, and gym operators.

Demand drivers are easier to identify than market size. One is the steady shift toward quantified training and assessment, visible in the company's pitch that multi-planar force measurement offers more useful information than simple rep counts or load tracking [Forbes, March 2022]. Another is the overlap between human performance and musculoskeletal health, which helps explain why an early partner such as Hospital for Special Surgery could also become a customer and investor [Fitt Insider, December 2021].

The available deployment figures, while at least partly company-sourced in media coverage, suggest there was early market pull beyond a handful of pilot users. Sports Business Journal reported that Proteus's version 2.0 machine was used by tens of thousands of users across 41 states and parts of Canada as of July 2022, while Sportico reported that more than 100 units were in use around the same period [Sports Business Journal, July 2022] [Sportico, 2022]. Those numbers do not establish revenue quality or retention, but they do indicate that the product was reaching multiple geographies and use settings by mid-2022.

Substitute markets and alternatives are also important here, even if the source set does not name direct competitors. Proteus can be evaluated against traditional strength equipment, sports performance testing tools, rehab assessment systems, and increasingly software-led training analytics that use cameras or wearable sensors. That substitution risk cuts both ways: it raises competitive pressure, but it also means Proteus is not dependent on a single narrow procurement budget if buyers accept the system as both equipment and data infrastructure [Forbes, March 2022] [TechFundingNews, July 2022].

The regulatory picture appears manageable but still relevant. Proteus's public materials say the device can collect health-related information, including heart rate, heart rate variability, ambient air temperature, activity type, and activity duration with explicit user consent, which implies ordinary privacy and data-governance obligations when selling into clinical or wellness settings [Proteus Motion, retrieved 2024]. There is no public evidence in the gathered materials that the product is being marketed as a regulated medical device, so the larger near-term constraint looks commercial rather than regulatory: enterprise hardware sales cycles are slower, budgets are discretionary in some channels, and buyers often need proof that new systems improve outcomes or utilization.

On balance, the market backdrop looks credible but still evidence-light. The company is pursuing a real convergence area, where performance training, rehab, and wellness increasingly share measurement tools, yet the public record does not provide third-party TAM work or independent outcome studies that would make the market case more definitive [Forbes, March 2022] [TechFundingNews, July 2022] [Proteus Motion, retrieved 2024].

Lightly corroborated -- This section relies on named public sources for buyer segments and deployment signals, but lacks independent third-party market-sizing data and includes some company-originated claims repeated in media coverage.

Competitive Landscape

Landscape

MIXED Proteus Motion sits in a crowded performance and rehabilitation stack, but its positioning is narrower than a general fitness device and broader than a single diagnostic tool: the public record points to a system meant to quantify and train force across multiple planes, with initial adoption among elite sports users and physical-therapy providers rather than mass-market consumers [Forbes, March 2022] [TechFundingNews, July 2022].

The practical comparison set therefore breaks into three lanes. In elite performance, Proteus competes for budget and floor space against established strength equipment, force-measurement systems, and coach-led assessment workflows, even where those alternatives are not named in the available reporting [Forbes, March 2022]. In rehabilitation and sports medicine, it appears to compete less on entertainment and more on whether a clinic wants a combined assessment-and-training platform instead of separate tools and therapist judgment, with Hospital for Special Surgery cited as an early collaborator that later became a customer and investor [Fitt Insider, December 2021]. In wellness and longevity, which the company has also targeted according to the public summary in the source set, the substitute is often not a direct machine competitor at all, but standard resistance equipment plus lighter-touch software layers that are likely cheaper to deploy, even if they do not offer the same three-dimensional measurement claim [Proteus Motion, retrieved 2024].

Proteus's edge today appears to rest on product architecture and early category credibility, not on a clearly demonstrated distribution moat. The strongest public evidence is consistent on differentiation: Forbes described the product's value as quantifying strength and power across multiple planes rather than simply tracking load or repetitions, while multiple company-adjacent sources emphasize patented hardware and software and a branded 3D Resistance system [Forbes, March 2022] [TechFundingNews, July 2022] [SP8 BALL TRAINING, retrieved 2026]. That can be durable if the measurement output becomes trusted by trainers, rehab providers, and athletes as a decision-making standard. It is more perishable if buyers continue to treat the machine as premium equipment rather than critical workflow infrastructure, because hardware advantages tend to narrow once adjacent vendors package similar testing into broader training environments.

The main exposure is visible in the go-to-market profile. Public reporting supports more than 100 units in use and usage across 41 states and parts of Canada by July 2022, which is meaningful for a capital-equipment business, but it does not yet establish channel ownership, recurring software dependence, or category control beyond early adopters [Sportico, 2022] [Sports Business Journal, July 2022]. That leaves Proteus exposed to two kinds of rival. First, entrenched equipment and rehab vendors can bundle adjacent functionality into existing customer relationships. Second, lower-cost substitutes can win buyers who care more about training throughput and price than measurement depth. The company also appears strongest in North American sports-performance circles; the public record here does not show a comparable hold in broader clinical networks or international distribution [Sports Business Journal, July 2022] [Tracxn, retrieved 2026].

The most plausible 18-month scenario is not a winner-take-all outcome, but a sorting between systems that become embedded in professional workflows and systems that remain specialty equipment. Hospital for Special Surgery is the clearest named winner if clinical validation and institutional adoption continue to matter, because its dual role as collaborator, customer, and investor suggests a reference account that can reinforce credibility in rehab and sports medicine [Fitt Insider, December 2021]. The clearest named loser if Proteus fails to move beyond athlete-led demand is Blake Griffin Enterprises as a signaling investor, since athlete-backed visibility helps with awareness but does not by itself solve repeatable enterprise distribution or clinical standard-setting [Sports Business Journal, July 2022].

Opportunity

PUBLIC The prize here is not a better gym machine, it is the chance to become a system of record for how strength and power are measured and trained across sports performance, rehab, and eventually broader wellness settings, if Proteus can turn an early hardware foothold into repeatable software and protocol adoption [Forbes, March 2022] [Sports Business Journal, July 2022].

The headline opportunity rests on a specific wedge. Proteus is selling a 3D resistance-training and strength-measurement system that aims to quantify force across multiple planes, where legacy strength tools usually record narrower outputs such as load or repetitions [Forbes, March 2022] [TechFundingNews, July 2022]. That matters because the early evidence shows the product has already found willing high-intent users, including elite athletes, sports-performance trainers, physical-therapy settings, and the Hospital for Special Surgery, which founder Sam Miller said was first a collaborator and later both a customer and investor [Fitt Insider, December 2021] [Sports Business Journal, July 2022] [CB Insights]. If that measurement layer becomes trusted, Proteus could plausibly occupy the same analytical position in human performance that specialized systems such as TrackMan hold in skill-specific sports data, which is the comparison Forbes explicitly raised in 2022 [Forbes, March 2022].

The public record supports a few distinct routes to scale rather than a single all-or-nothing bet. The common thread is that each route starts with a premium installed base and then broadens through repeatable use cases, software workflows, or customer standardization [Sports Business Journal, July 2022] [Sportico, 2022].

Scenario What happens Catalyst Why it's plausible
Elite performance standard Proteus becomes a default assessment and training device across pro and collegiate performance programs, then expands through trainer influence into adjacent facilities More athlete-backed distribution and operator-led commercialization following the 2025 financing and CEO transition [Sports Business Journal, October 2025] The company had more than 100 units in use by July 2022 and reported usage across 41 states and parts of Canada, with named athlete users and backing from sports-focused investors [Sportico, 2022] [Sports Business Journal, July 2022]
Rehab-to-clinic platform Proteus deepens in physical therapy and orthopedic rehab, where quantified multi-planar strength data can support reassessment and care progression workflows Clinical adoption anchored by existing relationship depth with Hospital for Special Surgery and similar rehab providers [Fitt Insider, December 2021] [CB Insights] Public reporting already places the product in physical therapy settings, and HSS is cited as collaborator, customer, and investor, which suggests more than a consumer-fitness use case [Fitt Insider, December 2021] [Forbes, March 2022]
Software layer on top of hardware The machine becomes the sensor, while software, protocols, and benchmarking become the higher-value layer sold across training, rehab, and wellness networks Product automation around assessments and training programs, consistent with Miller's stated aim to embed elite trainers' expertise into software [TechFundingNews, July 2022] Proteus already positions itself around assessments plus resistance training, not hardware alone, and the differentiation in public coverage centers on data capture rather than a standalone exercise device [TechFundingNews, July 2022] [Forbes, March 2022]

The compounding mechanism, if it forms, would likely come from protocols and data rather than classic network effects. Each installed unit can generate repeated assessments, repeated training sessions, and longitudinal performance data, which in turn can make the system more useful for benchmarking, program design, and customer retention [TechFundingNews, July 2022] [Proteus Motion, retrieved 2024]. There are early signs of that loop in the reported footprint: more than 100 units in use by July 2022, tens of thousands of users, and deployments spanning 41 states and parts of Canada [Sportico, 2022] [Sports Business Journal, July 2022]. If the company can translate those sessions into trusted norms by athlete type, injury profile, or training objective, the software layer gets harder to replace than the machine itself. That is the part of the thesis that could improve margins over time, because the hardware sale opens the door but the measurement history and programmed workflows may become the reason an account expands.

The size of the win is harder to pin down because no credible market-size figure or close public comparable is established in the provided sources. The cleanest public anchor is Proteus's reported $40 million valuation around its 2021 seed round and again in March 2022 coverage, before the July 2022 Series A brought cumulative funding to $17 million [Sportico, October 2021] [Forbes, March 2022] [Sportico, 2022]. On that base, a plausible upside case is not a modest hardware business but a much larger performance-and-rehab data platform. If the software-layer scenario takes hold and Proteus becomes a standard measurement system across elite sports and high-end rehab networks, the company could be worth several multiples of that early valuation, potentially in the low hundreds of millions of dollars (scenario, not a forecast). The evidence does not support a tighter range yet, but it does support the core proposition that the company has already moved beyond prototype status into a real installed-base business with recognized strategic backers [Sports Business Journal, July 2022] [Sports Business Journal, October 2025].

Lightly corroborated -- Based primarily on Forbes, Sports Business Journal, Sportico, and company-linked sources; the upside framing is analytical, and several product-expansion claims remain only partially corroborated by independent public reporting.

Sources

Public sources

  1. [Proteus Motion, retrieved 2024] Proteus® - Measure Strength & Power With Every Movement | https://proteusmotion.com/

  2. [LinkedIn, retrieved 2024] Proteus Motion | LinkedIn | https://www.linkedin.com/company/proteus-motion-inc

  3. [Crunchbase, retrieved 2024] Proteus Motion - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/boston-biomotion

  4. [Fitt Insider, December 2021] Startup QA: Proteus Motion Founder Sam Miller | https://insider.fitt.co/startup-qa-proteus-motion-founder-sam-miller/

  5. [Sportico, October 2021] Fitness Machine Startup Proteus Motion Raises $3 Million Seed Round | https://www.sportico.com/business/finance/2021/proteus-motion-3-million-seed-round-1234643974/

  6. [Sports Business Journal, July 2022] Proteus Motion Raises $8.5 Million in Series A Funding With Blake Griffin Joining Round | https://www.sportsbusinessjournal.com/Daily/Issues/2022/07/20/Technology/proteus-motion-raises-85-million-in-series-a-funding-with-blake-griffin-joining-round/

  7. [Tracxn, retrieved 2026] Proteus Motion - Company Profile | https://tracxn.com/d/companies/proteus-motion/__fK3nQ2mV6g6jv6q0gA0Q7tQf8m2u6xH0Jw2p8x8mJ4

  8. [Forbes, March 2022] Proteus Motion Aims To Be The TrackMan Of Power Testing | https://www.forbes.com/sites/mikedojc/2022/03/23/proteus-motion-aims-to-be-the-trackman-of-power-testing/

  9. [TechFundingNews, July 2022] Backed by athlete investors, Proteus Motion scoops $8.5M for 3D resistance training machine | https://techfundingnews.com/backed-by-athlete-investors-proteus-motion-scoops-8-5m-for-3d-resistance-training-machine/

  10. [Sports Business Journal, October 2025] Proteus Motion raises $2.75 million investment round | https://www.sportsbusinessjournal.com/sb-blogs/sbj-power-up/2025/10/30

  11. [Sportico, 2022] Fitness Machine Startup Proteus Motion Raises $8.5 Million | https://www.sportico.com/business/tech/2022/fitness-machine-startup-proteus-series-a-1234682957/

  12. [Planet Fastpitch, retrieved 2026] Proteus Motion 3D Resistance Training System | https://planetfastpitch.com/products/proteus-motion

  13. [SP8 BALL TRAINING, retrieved 2026] Proteus Motion | https://sp8balltraining.com/pages/proteus-motion

  14. [CB Insights] CB Insights | https://www.cbinsights.com/company/boston-biomotion

Articles about Proteus Motion

View on Startuply.vc